Targacept, Inc.
Jeff Brennan has a diverse work experience in the biopharmaceutical industry. Jeff started their career at Sanofi as the Vice President of Commercial Development in 1997 and held this position until 2003. Jeff then joined Targacept, Inc. as the Chief Business Officer and Senior Vice President of Business and Commercial Development. After that, they became the President and CEO of Link BioPharm Advisors, LLC in 2013.
Jeff Brennan attended Central Connecticut State University from 1975 to 1979, where they earned a Bachelor of Science degree in Marketing and Economics.
This person is not in any teams
Targacept, Inc.
Targacept is developing a diverse pipeline of innovative NNR Therapeutics™ for difficult-to-treat diseases and disorders of the nervous system. NNR Therapeutics selectively modulate the activity of specific neuronal nicotinic receptors, unique proteins that regulate vital biological functions that are impaired in various disease states. Targacept’s clinical pipeline includes multiple Phase 2 product candidates, all representing first-in-class opportunities. Targacept leverages its scientific leadership and diverse pipeline to attract significant collaborations with global pharmaceutical companies. For more information, please visit www.targacept.com.